Level Biotechnology (3118) — Free Cash Flow Generation Index
Level Biotechnology (3118) has a Free Cash Flow Generation Index of 0.62x as of September 2025. Free cash flow of NT$7.37 Million represents 1% of operating cash flow (NT$11.81 Million). See Level Biotechnology working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Level Biotechnology Free Cash Flow Generation Index (2017–2024)
Historical FCF Generation Index trend for Level Biotechnology across 8 annual periods. Explore Level Biotechnology cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Level Biotechnology (2017–2024)
Year-by-year Free Cash Flow Generation Index for Level Biotechnology. For the full company profile including market capitalisation, see Level Biotechnology market capitalisation.
| Year | FCG Index | Free Cash Flow (TWD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -2.49x | NT$-159.58 Million | NT$64.10 Million | NT$223.68 Million | ▼ -379.5% |
| 2023 | 0.89x | NT$62.54 Million | NT$70.21 Million | NT$7.67 Million | ▼ -0.6% |
| 2022 | 0.90x | NT$58.33 Million | NT$65.07 Million | NT$6.74 Million | ▼ -4.8% |
| 2021 | 0.94x | NT$146.79 Million | NT$155.95 Million | NT$9.15 Million | ▼ -2.9% |
| 2020 | 0.97x | NT$80.69 Million | NT$83.23 Million | NT$2.54 Million | ▼ -0.8% |
| 2019 | 0.98x | NT$106.60 Million | NT$109.02 Million | NT$2.43 Million | ▲ +7.9% |
| 2018 | 0.91x | NT$24.26 Million | NT$26.77 Million | NT$2.51 Million | ▲ +3.3% |
| 2017 | 0.88x | NT$62.55 Million | NT$71.29 Million | NT$10.83 Million | — |